Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India · Delayed Price · Currency is INR 1,706.70
-27.10 (-1.56%)
Jul 31, 2025, 3:29 PM IST
Sun Pharmaceutical Industries Employees
Sun Pharmaceutical Industries had 43,000 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
43,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$12,227,544
Profits / Employee
$2,541,637
Market Cap
4,159.97B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 43,000 | 0 | - |
| Mar 31, 2024 | 43,000 | 2,000 | 4.88% |
| Mar 31, 2023 | 41,000 | 3,000 | 7.89% |
| Mar 31, 2022 | 38,000 | 1,000 | 2.70% |
| Mar 31, 2021 | 37,000 | 1,000 | 2.78% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Divi's Laboratories | 10,542 |
| Cipla | 30,313 |
| Apollo Hospitals Enterprise | 83,147 |
| Mankind Pharma | 19,540 |
| Zydus Lifesciences | 27,917 |
| Aurobindo Pharma | 26,015 |
| Fortis Healthcare | 12,237 |
| Glenmark Pharmaceuticals | 14,989 |
Sun Pharmaceutical Industries News
- 7 days ago - Sun Pharma subsidiaries settle US antitrust litigation for $200 million - Business Upturn
- 10 days ago - Sun Pharma reports positive results from Phase 3 trials for ILUMYA - Business Upturn
- 14 days ago - Tata Technologies, Sun Pharma & more: Top stocks on brokers' radar for July 17, 2025 - The Times of India
- 15 days ago - Nifty 50 top losers today, July 16: Shriram Finance, Eternal, Sun Pharma, Cipla, Tata Steel and more - Business Upturn
- 16 days ago - Nifty top gainers today, July 15: Hero MotoCorp, Bajaj Auto, Sun Pharma, Shriram Finance, Apollo Hospitals and more - Business Upturn
- 17 days ago - Sun Pharma Announces Launch of LEQSELVI™ (deuruxolitinib) in the United States for the Treatment of Severe Alopecia Areata - Benzinga
- 17 days ago - Sun Pharma announces settlement with Incyte Corporation over LEQSELVI litigation - Business Upturn
- 17 days ago - Morgan Stanley turns selective on Indian pharma, initiates call on Sun Pharma, Lupin, DRL, CIPLA shares - Business Upturn